Evidence map›Paper›PMID 24630952›Full record

ReviewVeterinary immunology and immunopathology2014

Advances in swine immunology help move vaccine technology forward.

Michael P Murtaugh

Abstract readReview
In one paragraph

Review in Veterinary immunology and immunopathology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Analysis of efficacy obtained with a trivalent inactivatedCanadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2017
    Trial
  2. Minimum dose, antigen content, and immunization duration of a trivalent vaccine of inactivatedCanadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2016
    Trial
  3. Article
  4. Pathogens (Basel, Switzerland) · 2023
    Review
  5. Use of Nanostructured Silica SBA-15 as an Oral Vaccine Adjuvant to ControlInternational journal of molecular sciences · 2023
    Article
  6. Article
  7. Microorganisms · 2021
    Article
  8. Prevalence ofAnimals : an open access journal from MDPI · 2019
    Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Michael P MurtaughDepartment of Veterinary and Biomedical Sciences, University of Minnesota, 1971 Commonwealth Avenue, St. Paul, MN 55108, USA. Electronic address: murta001@umn.edu.
University of Minnesota · US

Funding

Minnesota Training Program in VirologyT32AI083196 · NIAID · UNIVERSITY OF MINNESOTA · PI Louis M Mansky · 2010 to 2026
$3.2M
NIAID NIH HHS T32 AI083196
6 · The paper itself

Abstract

In veterinary animal species, vaccines are the primary tool for disease prevention, a key tool for treatment of infection, and essential for helping maintain animal welfare and productivity. Traditional vaccine development by trial-and-error has achieved many successes. However, effective vaccines that provide solid cross-protective immunity with excellent safety are still needed for many diseases. The path to development of vaccines against difficult pathogens requires recognition of uniquely evolved immunological interactions of individual animal hosts and their specific pathogens. Here, general principles that currently guide veterinary immunology and vaccinology research are reviewed, with an emphasis on examples from swine. Advances in genomics and proteomics now provide the community with powerful tools for elucidation of regulatory and effector mechanisms of protective immunity that provide new opportunities for successful translation of immunological discoveries into safe and effective vaccines.

Indexed as

Immunity, InnateImmunity, MucosalAnimalsInfectionsSwineVaccinesVaccinesAdaptive immunityB-cellCholera toxinInnate immunityMucosal immunityPRRSVT-cell

Identifiers

PMID24630952
PMCPMC4107305
OpenAlexW2100809700

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.